Crewe Advisors’s Qiagen QGEN Stock Holding History

Crewe Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-43	Closed	-$1.93K	–	1121
2025 Q4	$1.93K	Hold	43	–	–	﹤0.01%	888
2025 Q3	$1.92K	Buy	+43	New	+$2.06K	﹤0.01%	855
2022 Q4	–	Sell	-33	Closed	-$1K	–	1208
2022 Q3	$1K	Buy	+33	New	+$1.63K	﹤0.01%	1185

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Crewe Advisors's QGEN Position: Q1 2026 in Review

Crewe Advisors sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 43 shares — an estimated $1.93K sold.

Crewe Advisors first reported a position in QGEN in Q3 2022 and held it in 3 quarters. The position peaked at $1.93K in Q4 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

Crewe Advisors reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
Crewe Advisors sold 43 Qiagen shares in Q1 2026, an estimated $1.93K.
Crewe Advisors first reported a position in Qiagen in Q3 2022 and held it in 3 quarters.
Crewe Advisors's Qiagen position peaked at $1.93K in Q4 2025.
346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Crewe Advisors's 13F filing for Q1 2026, filed 7 May 2026.